BHAVANI PEDDAGOVINDU

Allopathic & Osteopathic Physicians|Internal Medicine COOS BAY, OR NPI 1013167303

General Payments — all program years on this page

$522.71

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $292.08 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $292.0820

By paying entity

Latest program year (PY2019) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $230.6316
2019 $292.0820

Records — PY2019 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
651317363 E.R. Squibb & Sons, L.L.C. $12.53 03/20/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
655726581 Astellas Pharma US Inc $22.81 09/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
657701663 Lilly USA, LLC $15.61 05/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
657712097 Lilly USA, LLC $11.45 04/02/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659180073 Janssen Pharmaceuticals, Inc $16.66 03/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659180077 Janssen Pharmaceuticals, Inc $22.50 04/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659786565 Novartis Pharmaceuticals Corporation $19.30 06/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
662211333 Amgen Inc. $13.23 01/24/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
662211335 Amgen Inc. $12.49 05/01/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670763241 GlaxoSmithKline, LLC. $14.58 03/28/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671492115 GlaxoSmithKline, LLC. $14.78 11/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671904259 PFIZER INC. $13.70 03/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673227249 PFIZER INC. $12.22 10/31/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685681431 AstraZeneca Pharmaceuticals LP $12.20 07/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685723927 AstraZeneca Pharmaceuticals LP $12.54 09/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685759633 AstraZeneca Pharmaceuticals LP $12.18 05/08/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685788981 AstraZeneca Pharmaceuticals LP $12.94 08/01/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
694787077 Mylan Specialty L.P. $11.28 06/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700214935 Boehringer Ingelheim Pharmaceuticals, Inc. $13.22 05/15/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700214937 Boehringer Ingelheim Pharmaceuticals, Inc. $15.86 02/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.